IMD-Kongress 2025
Over the past twenty years, it has been shown that so-called "silent inflammation" - also known as metaflammation - plays a central role in the development and progression of classic metabolic diseases of the metabolic syndrome. These include obesity, type 2 diabetes, cardiovascular diseases and neurodegenerative diseases such as Alzheimer's disease and inflammatory bowel disease.
Modern lifestyle and environmental factors play a key role in the misprogramming of the neuroendocrine immune system and immune cells. In addition, fat cells themselves release mediators and hormones that maintain chronic inflammation.
In Germany, around 30-35% of the population is affected by metabolic syndrome, and the numbers continue to rise.
How such inflammatory processes arise, why they increase the risk of numerous diseases in the long term, what role stress and changes in the intestine play in this, and what preventive and therapeutic approaches exist are the central topics of this year's IMD annual congress.
Seminaris CampusHotel Berlin - Science & Conference Center "The Dahlem Cube", Takustraße 39, 14195
Berlin